Nuclear medicine, the use of nuclear science and technology and means of diagnosis and treatment of diseases, is one of the main means of modern medicine. Nuclear medicine is one of the main medical technology departments in hospitals, mainly to carry out nuclear medicine examination program, is one of the effective means to assist the clinical departments to make a correct diagnosis of diseases.
Nuclear medicine is the use of nuclear science and technology and means of diagnosis and treatment of disease, is one of the main means of modern medicine. Nuclear medicine is one of the main medical technology departments in the hospital, which mainly carries out nuclear medicine examination programs, and is one of the effective means to assist the clinical departments to make correct diagnosis of diseases. It has a number of advanced equipments such as SPECT and thyroid function meter. The clinical diagnosis and treatment carried out by this department have reached the domestic advanced level. It has conducted research on the imaging diagnosis of thyroid diseases, tumors, coronary heart disease, renal diseases and the treatment of hyperthyroidism and bone metastatic cancer, and has achieved good medical and social benefits.
1. Imaging and functional diagnosis: using 18F-FDG, 67Ga, 99mTc-MIBI, 99mTc(V)-DMS, 131I-MIBG, 131I, and other tumor imaging agents for the characterization of lumps in various parts of the body, tumor staging, auxiliary localization for treatment planning, efficacy analysis, follow-up, diagnosis of recurrence or metastasis, and carrying out research on the bones of the whole body, parotid, thyroid, chest and abdomen. We also carry out imaging of important organs such as bones, parotid gland, thyroid gland, chest and abdomen, identification of hemangiomas, localization of gastrointestinal hemorrhage, analysis of multidrug resistance of tumors, localization of tumor hypoxic areas, sentinel or conventional lymph node imaging of lymphomas, breast, cervical, and rectal cancers, and functional analysis of the thyroid gland, kidneys, and the heart.
2. Marker immunoassay: carry out AFP, CEA, CA125, CA199, CA153, CA242, CA50, CA724, SCCA, SYFRA21-1, NSE, TSGF, PSA, FPSA, FT3, FT4, TSH, TGA, TPOA, TG, CT, PTH, T, E2, PRL, LH, FSH, HCG-β, β2MG, SMb, CKMB, TnI and other tumor markers, hormones and cardiac enzyme profiling to determine the source of the tumor, metastasis or recurrence, the effect of the treatment and the damage to normal tissues. It was reported daily ~ 1 time per week.
3. Radionuclide therapy: with 153Sm-EDTMP, 89SrCl, 99Tc-MDP, 131I, 32P colloid and other radiopharmaceuticals, bone metastatic tumors, thyroid function autonomous adenomas, hyperthyroidism, and malignant thoracic and abdominal fluids, etc., to improve the quality of life of patients with tumors.
4. Nuclear Medicine Tumor Census: Using the above equipment and methods, carry out whole-body, non-invasive and rapid tumor census.